Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
Journal of the American Heart Association
|
May 16, 2022
Ultrashort Door-to-Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019
Robert Mikulík, Michal Bar, Silvie Bělašková, et al.
Blood
|
January 15, 2011
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
Erik A Nelson, Sarah R Walker, Ellen Weisberg, et al.
Journal of Neurology
|
March 25, 2011
Decompressive surgery for malignant supratentorial infarction remains underutilized after guideline publication
Michal Bar, Robert Mikulik, David Skoloudik, et al.
Genes & Cancer
|
December 25, 2012
The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations
Erik A Nelson, Sarah R Walker, Michael Xiang, et al.
Circulation. Cardiovascular Quality and Outcomes
|
January 31, 2022
Between-Center Variation in Outcome After Endovascular Treatment of Acute Stroke: Analysis of Two Nationwide Registries
Paula M Janssen, Katrine van Overhagen, Jan Vinklárek, et al.
Neurology. Clinical Practice
|
August 26, 2024
Utilization, Workflow, and Outcomes of Endovascular Thrombectomy in Patients With vs Without Premorbid Disability in a National Registry
Aravind Ganesh, Ondrej Volny, Ingrid Kovacova, et al.
Biomedicines
|
February 24, 2024
Intravenous Thrombolysis in Posterior versus Anterior Circulation Stroke: Clinical Outcome Differs Only in Patients with Large Vessel Occlusion
Simona Halúsková, Roman Herzig, Robert Mikulík, et al.
Hemasphere
|
March 15, 2021
Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies
Jonathan Feld, Douglas Tremblay, Mikaela Dougherty, et al.
Blood
|
June 7, 2015
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma
Salvia Jain, Dina Stroopinsky, Li Yin, et al.
Blood
|
September 17, 2014
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
Rafael Bejar, Allegra Lord, Kristen Stevenson, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
Journal of the American Heart Association
|
May 16, 2022
Ultrashort Door-to-Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019
Robert Mikulík, Michal Bar, Silvie Bělašková, et al.
Blood
|
January 15, 2011
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
Erik A Nelson, Sarah R Walker, Ellen Weisberg, et al.
Journal of Neurology
|
March 25, 2011
Decompressive surgery for malignant supratentorial infarction remains underutilized after guideline publication
Michal Bar, Robert Mikulik, David Skoloudik, et al.
Genes & Cancer
|
December 25, 2012
The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations
Erik A Nelson, Sarah R Walker, Michael Xiang, et al.
Circulation. Cardiovascular Quality and Outcomes
|
January 31, 2022
Between-Center Variation in Outcome After Endovascular Treatment of Acute Stroke: Analysis of Two Nationwide Registries
Paula M Janssen, Katrine van Overhagen, Jan Vinklárek, et al.
Neurology. Clinical Practice
|
August 26, 2024
Utilization, Workflow, and Outcomes of Endovascular Thrombectomy in Patients With vs Without Premorbid Disability in a National Registry
Aravind Ganesh, Ondrej Volny, Ingrid Kovacova, et al.
Biomedicines
|
February 24, 2024
Intravenous Thrombolysis in Posterior versus Anterior Circulation Stroke: Clinical Outcome Differs Only in Patients with Large Vessel Occlusion
Simona Halúsková, Roman Herzig, Robert Mikulík, et al.
Hemasphere
|
March 15, 2021
Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies
Jonathan Feld, Douglas Tremblay, Mikaela Dougherty, et al.
Blood
|
June 7, 2015
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma
Salvia Jain, Dina Stroopinsky, Li Yin, et al.
Blood
|
September 17, 2014
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
Rafael Bejar, Allegra Lord, Kristen Stevenson, et al.
Page
of 11